Conexeu Sciences Inc. (CNXU) — Institutional Holders, Q2 2026

8 institutional investment managers reported a CNXU position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $282.5K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

CNXU 13F holders ranked 1–8 of 8

Institutional investors reporting a position in Conexeu Sciences Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
UBS Group AG#1 · 12,264 sh$133.9K—
MORGAN STANLEY#2 · 5,871 sh$64.1K—
CITIGROUP#3 · 5,219 sh$57.0K—
HOLLENCREST SECURITIES#4 · 1,000 sh$10.9K—
ROYAL BANK OF CANADA#5 · 887 sh$10.0K—
Integrated Wealth Concepts#6 · 400 sh$4.4K—
JONES FINANCIAL COMPANIES LLLP#7 · 100 sh$1.1K—
OSAIC#8 · 100 sh$1.1K—

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for the prior quarter without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.